A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Part of paid clinical trials in Los Alamitos, California.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT07061288
- Phase
- PHASE1
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Not accepted
Interventions
- KarXT — DRUGSpecified dose on specified days
Study Details
A study to evaluate the safety, tolerability, and PK of an injectable form of KarXT in participants with schizophrenia
Key Dates
- First listed
- Jul 11, 2025
- Start date
- Sep 3, 2025
- Status verified
- Jun 2026
- Primary completion
- Jun 21, 2027
- Completion
- Oct 15, 2027
Study Design
- Enrollment
- 116 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: Administration of KarXT
Primary Outcome Measure
Number of participants with adverse events (AEs) [ Time Frame: Up to 3 weeks ]
Central Contacts
- BMS Clinical Trials Contact Center www.BMSClinicalTrials.com855-907-3286
- First line of the email MUST contain NCT # and Site #.
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Collaborative Neuroscience Research, LLC | Los Alamitos | California | 90720-3118 | David Walling, Site 0001 714-799-7799 |
| Research Centers of America ( Hollywood ) | Hollywood | Florida | 33024 | Edwin Gomez, Site 0005 954-990-7649 |
| Innovative Clinical Research, Inc. | Miami Lakes | Florida | 33016 | Rishi Kakar, Site 0004 786-512-4106 |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | Elyssa Barron, Site 0008 404-881-5800 |
| CenExel iResearch, LLC | Decatur | Georgia | 30030 | Kimball Johnson, Site 0003 312-942-5592 |
| Uptown Research Institute | Chicago | Illinois | 60640 | John Sonnenberg, Site 0002 773-968-9868 |
| Hassman Research Institute Marlton Site | Marlton | New Jersey | 08053 | Elan Cohen, Site 0007 856-452-9901 |
| Community Clinical Research | Austin | Texas | 78754 | David Brown, Site 0006 512-323-2622 |
Find similar trials in Los Alamitos, CA
By condition
By specialty
By research site
Related Studies
- Database Registry for Neural Network Biomarkers in PsychosisRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With SchizophreniaPHASE3 · Recruiting · Gedeon Richter Plc. · Culver City, California
- Ocrelizumab for Psychosis by AutoimmunityPHASE1/PHASE2 · Recruiting · The Methodist Hospital Research Institute · Houston, Texas
- Imaging Synapses With [11C] UCB-J in the Human BrainPHASE1 · Recruiting · Davidzon, Guido, M.D. · Palo Alto, California